How can European Life Sciences Compete for More Capital? | McDermott

How can European Life Sciences Compete for More Capital?

Overview


McDermott Will & Emery and Paris Healthcare Drinks are pleased to invite you to a round table and networking event discussing the difficulty life sciences companies can face in competing for capital and how to overcome those challenges.

The science is there, as are top researchers and outstanding companies offering disruptive technologies and products. Supportive public polices provide numerous subsidies and favorable legal frameworks… yet Europe is still lagging far behind the United States and China in terms of raising capital and attracting investors.

Can the situation change? What will trigger change for better and more accessible funding for European life sciences companies? Join us for an in depth discussion and the opportunity for interactive debate with our key speakers:

  • Marietta Wu – Managing Partner, Quan Capital
  • Thierry Laugel – Managing Partner, Kurma Partners
  • Emmanuelle Trombe – Head of the Paris Life Sciences Team, McDermott Will & Emery

For any queries, please contact Barbara Bebiano.

Dig Deeper

Webinar / McDermott Event / July 1, 2025

Global Antitrust Update | Webinar Series - Summer 2025

Boston, MA / Speaking Engagements / June 16 – 19, 2025

BIO International Convention 2025

Paris, France / Speaking Engagements / June 17, 2025

Innovative Medical Device Start Ups Day 2025 | SNITEM

Berlin / McDermott Event / June 3, 2025

McDermott SuperReturn Reception 2025

Arlington, VA / Speaking Engagements / May 30, 2025

AI: The Next Level